These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13852112)

  • 21. Triamcinolone acetonide in the topical treatment of selected dermatoses, with special reference to the effectiveness of the 0.5 per cent concentration.
    WITTEN VH; SULZBERGER MB; ARTHUR GW
    Clin Pharmacol Ther; 1960; 1():294-7. PubMed ID: 13845483
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of calcaneal spur inflammation with triamcinolone acetonide.
    MICHAEL BH
    J Am Podiatry Assoc; 1961 Nov; 51():801-3. PubMed ID: 14473311
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations upon the use of topical triamcinolone acetonide preparations in various concentrations.
    COHEN HJ; BAER RL
    Dermatologica; 1961 Feb; 122():116-9. PubMed ID: 13694376
    [No Abstract]   [Full Text] [Related]  

  • 24. The intralesional use of triamcinolone acetonide in psoriasis. A double blind study.
    HASEGAWA J; LIVINGSTON W
    Arch Dermatol; 1962 Feb; 85():258-60. PubMed ID: 13905149
    [No Abstract]   [Full Text] [Related]  

  • 25. Intra-articular injections of triaMCInolone acetonide in arthritic conditions.
    MILLER DS
    Clin Med (Northfield); 1961 Jun; 8():1161-4. PubMed ID: 15445476
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of triamcinolone acetonide in the topical treatment of eczematous eruptions.
    RUSSO JJ; NARDACCI AW
    N Y State J Med; 1959 Nov; 59():3964-6. PubMed ID: 14440339
    [No Abstract]   [Full Text] [Related]  

  • 27. Continued studies using a powder adhesive vehicle. Triamcinolone acetonide in the treatment of oral mucous membrane lesions.
    ZEGARELLI EV; KUTSCHER AH; SILVERS HF
    Arch Dermatol; 1961 Dec; 84():1035-6. PubMed ID: 14010006
    [No Abstract]   [Full Text] [Related]  

  • 28. Triamcinolone acetonide cream in a double-blind test.
    POLANO MK
    Arch Dermatol; 1961 Feb; 83():214-6. PubMed ID: 13736688
    [No Abstract]   [Full Text] [Related]  

  • 29. Triamcinolone acetonide in the treatment of erosive lichen planus of the oral mucosae. Preliminary report.
    ZEGARELLI EV; KUTSCHER AH
    Arch Dermatol; 1960 Dec; 82():1010-1. PubMed ID: 13788087
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of cutaneous candidiasis and pyodermas with anti-infectives and triamcinolone acetonide in a single topical preparation.
    HOWELL CM
    Antibiot Annu; 1959-1960; 7():644-8. PubMed ID: 13852536
    [No Abstract]   [Full Text] [Related]  

  • 31. A dose response study with triamcinolone acetonide: a double-blind paired comparison.
    OLANSKY S
    Curr Ther Res Clin Exp; 1962 Jun; 4():310-2. PubMed ID: 14481684
    [No Abstract]   [Full Text] [Related]  

  • 32. Intradermal triamcinolone acetonide and diacetate: healing of persistent penile plaques due to distinctive, exudative, discoid and lichenoid chronic dermatosis.
    ORENTREICH N; MARCH C
    J Urol; 1961 May; 85():827-8. PubMed ID: 13731134
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical laboratory studies on a new topical corticosteroid-triaMCInolone acetonide.
    KUTSCHER AH; ZEGARELLI EV; SILVERS HF; PIRO JD
    Oral Surg Oral Med Oral Pathol; 1961 Aug; 14():938-41. PubMed ID: 13755435
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of kenacort (triamcinolone) in the treatment of uveitis.
    ZAVELL S; BLAYDES JE; ANHALT EF; KARA GB
    Am J Ophthalmol; 1959 Dec; 48():777-82. PubMed ID: 13847101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Kenacort-A ointment ophthalmic on ocular diseases].
    TOKUDA H
    Rinsho Ganka; 1961 Oct; 15():1085-7. PubMed ID: 13921589
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective use of intramuscular triamcinolone acetonide in pseudogout.
    Roane DW; Harris MD; Carpenter MT; Finger DR; Jarek MJ; Alloway JA; Erickson AR; Venanzi WE; Drehmer TJ
    J Rheumatol; 1997 Jun; 24(6):1168-70. PubMed ID: 9195527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes.
    López-García F; Vázquez-Autón JM; Gil F; Latoore R; Moreno F; Villalaín J; Gómez-Fernández JC
    J Pharm Pharmacol; 1993 Jun; 45(6):576-8. PubMed ID: 8103110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE USEFULNESS OF TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ARTHRITIC DISORDERS.
    SCHWARTZ S
    Curr Ther Res Clin Exp; 1963 Aug; 5():431-6. PubMed ID: 14057780
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide.
    McCarty DJ; Harman JG; Grassanovich JL; Qian C
    J Rheumatol; 1995 Sep; 22(9):1631-5. PubMed ID: 8523335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.